E.g., 04/27/2024
E.g., 04/27/2024
Titlesort ascending Category Credit Event date Price
PARPi: Precision Medicine in Advanced Prostate Cancer Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
PARPi: Management of Adverse Events Webcast (2024)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
PARPi: Genetic Testing in Advanced Prostate Cancer - When and Who to Test Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 The American Urological Association (AUA) has developed a series of live virtual and on-demand educational offerings to further address the identified educational gaps and barriers in advanced prostate cancer care. Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessments, a three-part educational series to update urologists and advanced practice providers (APPs) on PARP-inhibitor (PARPi) treatment in advanced prostate cancer is being offered.
Novel Imaging for Genitourinary Cancers – Diagnostics and Theranostics Podcast (2023)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:
Live from AUA2023: Highlights in Advanced Prostate Cancer
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Live from AUA2023: Highlights in Advanced Prostate Cancer is a panel discussion filmed during the 2023 AUA Annual Meeting!
Infectious Complications Following Prostate Biopsy: Strategies for Reducing Infections and Reducing Health Care Costs Podcast (2023)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 This new AUAUniversity podcast episode will address mechanisms behind infectious complications as well as the health care consequences of infections following prostate biopsy. Faculty will present real world and trial data pertaining to rates and associated factors for infections and provide practical measures to reduce these complications, including transperineal and transrectal approach (standard enema; antibiotic enema; iodine/other rectal prep; needle disinfection).
Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice Webcast (2023)
    • 1.50 AMA PRA Category 1 Credit™
    • 1.50 Non-Physician Participation
$0.00 Incorporating the AUA/SUO Guideline on Advanced Prostate Cancer into Practice (2023) is an exciting new educational initiative to update urologists on the most recent clinical guideline for the management of advanced prostate cancer. This course features a Moderator and three other subject matter experts engaging in an interactive, interview-style presentation and discussion.  
Germline Testing in GU Cancers – How I Do It Podcast (2023)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:Germline Testing in GU Cancers – How I Do It (2023)
Germline Testing and Novel Approaches to Targeting Genetic Mutations in Prostate Cancer Podcast (2023)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:
Early Detection of Prostate Cancer: AUA/SUO Guideline Podcast (2023)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 Based on the documented need for additional education in prostate cancer, bladder cancer, and kidney cancer, the AUA has developed AUA Expert Exchange Podcast: Discussions in GU Cancer. The 2023 AUA Expert Exchange Podcast: Discussions in GU Cancer is designed to address very specific learning opportunities and reach the urologic practitioners in an easy, flexible way with smaller, targeted updates. To address the educational needs of the urologic care team, this episode will focus on:Early Detection of Prostate Cancer: AUA/SUO Guideline (2023)
Disparities in Care and Barriers to Access for Patients with Advanced Prostate Cancer Podcast (2023)
    • 0.50 AMA PRA Category 1 Credit™
    • 0.50 Non-Physician Participation
$0.00 Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA is offering phase two of an educational series to update urologists and advanced practice providers (APPs) on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment. Part II will consist of two live webinars, one designed specifically for urologists and the other for APPs. The live virtual courses will feature a multidisciplinary panel engaging in a lively discussion on this topic.
AUA2023 Highlights in Prostate Cancer (2023)
    • 1.25 AMA PRA Category 1 Credit™
    • 1.25 Non-Physician Participation
$0.00 To better meet the educational needs of urologists and urologic healthcare providers, the AUA gathered from a variety of sources, including comprehensive literature searches and membership surveys to determine where gaps exist in the knowledge, proficiency, and practice in regards to prostate cancer.  This scientific, peer-reviewed publication captures various elements of the AUA Annual Meeting pertaining to prostate cancer including plenary sessions and courses, and reproduces them into a monograph.
Advances in ADT: Part II: A Guide for Urologists (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
09/28/2023 $0.00
Advances in ADT: Part II: A Guide for APPs (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
09/26/2023 $0.00
Advances in ADT Part II: A Guide for Urologists Webcast (2023)
    • 1.00 AMA PRA Category 1 Credit™
    • 1.00 Non-Physician Participation
$0.00 Based on the documented need from the AUA Advanced Prostate Cancer Global Needs Assessment, the AUA has created Advances in ADT: Part II: A Guide for Urologists (2023), an educational offering to further update urologists on the latest advancements in androgen deprivation therapy (ADT) and prostate cancer treatment.

Pages